The contraceptive CHOICE project round up: What we did and what we learned

Clinical Obstetrics and Gynecology

Volumn 57, Issue 4, 2014, Pages 635-643

  McNicholas, Colleen ^a   Madden, Tessa ^a   Secura, Gina ^a   Peipert, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CHOICE project; Contraception; LARC

Indexed keywords

ETONOGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT;

ABORTION; ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTRACEPTION; CONTRACEPTIVE PATCH; COPPER INTRAUTERINE DEVICE; FAMILY PLANNING; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MIDDLE AGED; PATIENT COUNSELING; PREGNANCY RATE; PROSPECTIVE STUDY; UNITED STATES; UNPLANNED PREGNANCY; VAGINA RING; YOUNG ADULT; ATTITUDE TO HEALTH; COUNSELING; FEMALE CONTRACEPTIVE DEVICE; HEALTH CARE DELIVERY; INDUCED ABORTION; PREGNANCY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ABORTION, INDUCED; ADOLESCENT; ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE DEVICES, FEMALE; COUNSELING; FAMILY PLANNING SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTRAUTERINE DEVICES; PREGNANCY; PREGNANCY, UNPLANNED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84927606628     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0000000000000070     Document Type: Article

References (22)

1. Secura GM, Allsworth JE, Madden T, et al. The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol. 2010; 203:115 e111-115 e117.
2. Spain JE, Peipert JF, Madden T, et al. The Contraceptive CHOICE Project: recruiting women at highest risk for unintended pregnancy and sexually transmitted infection. J Women Health. 2010; 19:2233-2238.
3. Madden T, Mullersman JL, Omvig K.J., et al. Structured contraceptive counseling provided by the Contraceptive CHOICE Project. Contraception. 2013; 88:243-249.
4. Rinehart W, Rudy S, Drennan M. GATHER guide to counseling. Population reports. Series J, Family planning programs 1998; 48:1-31.
5. Eisenberg DL, Secura GM, Madden T.E., et al. Knowledge of contraceptive effectiveness. Am J Obstet Gynecol. 2012; 206:479 e471-479 e479.
6. Peipert JF, Zhao Q, Allsworth J.E., et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011; 117:1105-1113.
7. O'Neil-Callahan M, Peipert JF, Zhao Q, et al. Twenty-four-month continuation of reversible contraception. Obstet Gynecol. 2013; 122:1083-1091.
8. Grunloh DS, Casner T, Secura G.M., et al. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013; 122: 1214-1221.
9. Peipert JF, Madden T, Allsworth J.E., et al. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol. 2012; 120:1291-1297.
10. Secura GM, Adams T, Buckel C.M., et al. Change in sexual behavior with provision of no-cost contraception. Obstet Gynecol. 2014; 123:771-776.
11. Mestad R, Secura G, Allsworth J.E., et al. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011; 84:493-498.
12. Rosenstock JR, Peipert JF, Madden T, et al. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol. 2012; 120:1298-1305.
13. Secura G, Madden T, McNicholas C., et al. Provision of no-cost long-acting contraception and teen pregnancy. NEJM. 2014. (In press).
14. McNicholas C, Zhao Q, Secura G., et al. Contraceptive failures in overweight and obese combined hormonal contraceptive users. Obstet Gynecol. 2013; 121:585-592.
15. Xu H, Wade JA, Peipert J.F., et al. Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol. 2012; 120:21-26.
16. Nault AM, Peipert JF, Zhao Q, et al. Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxypro-gesterone acetate. Am J Obstet Gynecol. 2013; 208: 48 e41-48 e48.
17. Vickery Z, Madden T, Zhao Q., et al. Weight change at 12 months in users of three progestin-only contraceptive methods. Contraception. 2013; 88:503-508.
18. Madden T, Secura GM, Allsworth J.E., et al. Comparison of contraceptive method chosen by women with and without a recent history of induced abortion. Contraception. 2011; 84: 571-577.
19. Madden T, Eisenberg DL, Zhao Q, et al. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement. Obstet Gynecol. 2012; 120:1053-1059.
20. McNicholas C, Peipert JF, Maddipati R, et al. Sexually transmitted infection prevalence in a population seeking no-cost contraception. Sex Transm Dis. 2014; 40:546-551.
21. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance. 2010. Available at: http://www.cdc.gov/std/stats10/default.htm.
22. Graseck AS, Secura GM, Allsworth J.E., et al. Home compared with clinic-based screening for sexually transmitted infections: a randomized controlled trial. Obstet Gynecol. 2010; 116:1311-1318.